BDNF and amyotrophic lateral sclerosis: These observations have led to the clinical evaluation of BDNF as a therapeutic agent in patients affected by amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder affecting motor neurons in the spinal cord, brainstem and motor cortex [21].